KALA BIO, Inc.
KALA
$0.57
$0.011.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.58M | -1.62M | 686.00K | -7.56M | -11.16M |
| Total Depreciation and Amortization | -- | -- | 54.00K | 128.00K | 67.00K |
| Total Amortization of Deferred Charges | -- | -- | -475.00K | 116.00K | 173.00K |
| Total Other Non-Cash Items | -136.00K | 1.28M | -3.43M | -1.28M | 2.49M |
| Change in Net Operating Assets | 182.00K | -2.56M | -1.39M | -2.28M | 694.00K |
| Cash from Operations | -1.54M | -2.90M | -4.56M | -10.88M | -7.73M |
| Capital Expenditure | -- | -- | 0.00 | 1.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -7.00M | -- | -- | -16.00K |
| Cash from Investing | 0.00 | -7.00M | 0.00 | 1.00K | -16.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -19.92M | -30.00K | -2.53M |
| Issuance of Common Stock | -- | -- | 9.13M | 60.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 4.10M | 1.80M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 0.00 | 4.10M | -8.98M | 30.00K | -2.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.54M | -5.79M | -13.54M | -10.85M | -10.28M |